Publications by authors named "Cesar A Rodriguez"

Claim this Profile
S
SEOM-AEEMT consensus on occupational cancer and cancer-associated disability.
Laura Mezquita, Mª Teófila Vicente-Herrero, Patricia Cruz, Mª Victoria Ramírez Íñiguez de la Torre, Julia Hidalgo-Coloma

Clin Transl Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.
Yash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil, Christoph Zielinski, Manuel Ruiz-Borrego

JCO Precis Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer.
Eduardo Terán, Rebeca Lozano, César A Rodríguez, Mar Abad, Luis Figuero

Cancer Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety profile of trastuzumab deruxtecan in advanced breast cancer: Expert opinion on adverse event management.
Eva Ciruelos, Jose Ángel García-Sáenz, Joaquín Gavilá, Miguel Martín, César A Rodríguez

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study.
Antonio Llombart-Cussac, Antonio Anton-Torres, Beatriz Rojas, Raquel Andrés, Noelia Martinez

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers.
Xuan-Yu Mao, Jesus Perez-Losada, Mar Abad, Marta Rodríguez-González, Cesar A Rodríguez

World J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study.
Zsuzsanna Kahan, Miguel Gil-Gil, Manuel Ruiz-Borrego, Eva Carrasco, Eva Ciruelos, Juan de la Haba-Rodriguez

Eur J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.
Laura Pedraza-Nieto, Mónica Beunza-Sola, César A Rodríguez, Esther Moreno, María José Otero

Int J Clin Pharm· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palbociclib combined with endocrine therapy in heavily pretreated HR/HER2 advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP).
Luis Manso, Cristina Hernando, María Galán, Mafalda Oliveira, Miguel A Cabrera

Breast· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Eva M Ciruelos, Alvaro Montaño, César A Rodríguez, Encarnación González-Flores, Ana Lluch

Eur J Cancer Care (Engl)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q".
Rosario González Mancha, Montserrat Muñoz, Luis de la Cruz-Merino, Lourdes Calvo, Josefina Cruz, Cesar Augusto Rodriguez

Health Qual Life Outcomes· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement.
Ramon Colomer, Cristina Saura, Pedro Sánchez-Rovira, Tomás Pascual, Isabel T Rubio

Oncologist· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study.
Andrés Redondo, Manuel Ramos Vázquez, Luis Manso, Miguel J Gil Gil, Isabel Garau Llinas

Onco Targets Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer.
Cesar A Rodriguez, Teresa Martin, Rebeca Lozano, Amalia Gomez, Juan J Cruz

Breast J· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.
Javier Salvador, Jorge Aparicio, Francisco Javier Baron, Rosario Garcia-Campelo, Rocio Garcia-Carbonero, Cesar A Rodriguez

Clin Transl Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study.
Miguel Martin, Jan C Brase, Amparo Ruiz, Aleix Prat, Ralf Kronenwett, César A Rodriguez, Alvaro Rodriguez-Lescure

Breast Cancer Res Treat· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
Ramón De Las Peñas, Santiago Ponce, Fernando Henao, Carlos Camps Herrero, Enric Carcereny

Support Care Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.
Miguel Martín, Amparo Ruiz Simón, Manuel Ruiz Borrego, Nuria Ribelles, Álvaro Rodríguez-Lescure

J Clin Oncol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy.
Gaspar Esquerdo, Mercedes Doménech, Pilar López, Carme Pedro, Kenny Villadiego

Tumori· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Synthetic Biology Open Language (SBOL) provides a community standard for communicating designs in synthetic biology.
Michal Galdzicki, Kevin P Clancy, Ernst Oberortner, Matthew Pocock, Jacqueline Y Quinn, Cesar A Rodriguez

Nat Biotechnol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
Miguel Martin, Jan C Brase, Lourdes Calvo, Kristin Krappmann, Manuel Ruiz-Borrego, Cesar A Rodriguez, Alvaro Rodriguez-Lescure

Breast Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab in small tumours and in elderly women.
Joan Albanell, Eva M Ciruelos, Ana Lluch, Montserrat Muñoz, César A Rodríguez

Cancer Treat Rev· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study.
Pere Gascón, César A Rodríguez, Vicente Valentín, Jesús García Mata, Joan Carulla

Support Care Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Miguel Martín, Amparo Ruiz, Manuel Ruiz Borrego, Agustí Barnadas, Sonia González

J Clin Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes.
Jing Lu, Mingxin Wen, Yurong Huang, Xiuquan He, Yunshan Wang, Cesar A Rodriguez

Epigenetics· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis